Annual Operating Expenses
$33.84 M
+$1.44 M+4.45%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual total operating expenses is $33.84 million, with the most recent change of +$1.44 million (+4.45%) on December 31, 2023.
- During the last 3 years, EFTR annual operating expenses has risen by +$7.66 million (+29.27%).
- EFTR annual operating expenses is now at all-time high.
Performance
EFTR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$8.40 M
-$202.00 K-2.35%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly total operating expenses is $8.40 million, with the most recent change of -$202.00 thousand (-2.35%) on March 31, 2024.
- Over the past year, EFTR quarterly operating expenses has dropped by -$1.14 million (-11.95%).
- EFTR quarterly operating expenses is now -32.30% below its all-time high of $12.40 million, reached on December 31, 2021.
Performance
EFTR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
EFTR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.5% | -11.9% |
| 3 y3 years | +29.3% | -11.9% |
| 5 y5 years | +29.3% | -11.9% |
EFTR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.1% | -32.3% | +28.2% |
| 5 y | 5-year | at high | +29.3% | -32.3% | +66.5% |
| alltime | all time | at high | +29.3% | -32.3% | +66.5% |
EFFECTOR Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $8.40 M(-2.3%) |
| Dec 2023 | $33.84 M(+4.4%) | $8.60 M(+9.5%) |
| Sep 2023 | - | $7.86 M(0.0%) |
| Jun 2023 | - | $7.86 M(-17.6%) |
| Mar 2023 | - | $9.54 M(+9.3%) |
| Dec 2022 | $32.40 M | $8.72 M(-5.7%) |
| Sep 2022 | - | $9.25 M(+17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.88 M(+20.4%) |
| Mar 2022 | - | $6.55 M(-47.2%) |
| Dec 2021 | $31.90 M(+21.8%) | $12.40 M(+42.3%) |
| Sep 2021 | - | $8.71 M(+72.8%) |
| Jun 2021 | - | $5.04 M(-12.1%) |
| Mar 2021 | - | $5.74 M(+1.3%) |
| Dec 2020 | $26.18 M | $5.66 M(-27.8%) |
| Sep 2020 | - | $7.84 M |
FAQ
- What is eFFECTOR Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual operating expenses year-on-year change?
- What is eFFECTOR Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly operating expenses year-on-year change?
What is eFFECTOR Therapeutics annual total operating expenses?
The current annual operating expenses of EFTR is $33.84 M
What is the all time high annual operating expenses for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual total operating expenses is $33.84 M
What is eFFECTOR Therapeutics annual operating expenses year-on-year change?
Over the past year, EFTR annual total operating expenses has changed by +$1.44 M (+4.45%)
What is eFFECTOR Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of EFTR is $8.40 M
What is the all time high quarterly operating expenses for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly total operating expenses is $12.40 M
What is eFFECTOR Therapeutics quarterly operating expenses year-on-year change?
Over the past year, EFTR quarterly total operating expenses has changed by -$1.14 M (-11.95%)